Cardio Diagnostics Holdings Inc (CDIO)

Cardio Diagnostics Holdings Inc (CDIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.2M; returns 1 day -0.9%, 1 week +0.0%, 1 year -57.3%.

Cardio Diagnostics Holdings Inc. is a precision cardiovascular medicine company that leverages artificial intelligence and epigenetics to develop and commercialize diagnostic tests for cardiovascular disease. The company's core business revolves around its proprietary AI-driven Integrated Genetic-Epigenetic Engine.

Groups CDIO belongs to

• Healthcare
• Biotechnology
• Precision Medicine
• Artificial Intelligence
• Epigenetics
• Cardiovascular Therapies
• Medical Devices
• Health Diagnostics and Imaging
• AI in Healthcare
• Healthcare Technology
• Biopharmaceutical

CDIO financial model: income statement, cash flow and balance sheet